ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,776.92
0.08%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Longboard Pharmaceuticals Inc (LBPH)

  7. Longboard Pharmaceuticals Inc (LBPH) Noticias

LBPH

Longboard Pharmaceuticals (LBPH)

Longboard Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LBPH
FechaHoraFuenteTítuloSímboloCompañía
24/05/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
24/05/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
06/05/202415:01Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/05/202415:01Business WireLongboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/04/202408:00Business WireLongboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15NASDAQ:LBPHLongboard Pharmaceuticals Inc
12/03/202415:01Business WireLongboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/02/202407:30Business WireLongboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in FebruaryNASDAQ:LBPHLongboard Pharmaceuticals Inc
08/01/202415:05Business WireLongboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202415:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202420:40Business WireLongboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202419:59Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202415:01Business WireLongboard Pharmaceuticals Announces Commencement of Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202407:00Business WireLongboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
01/01/202415:47Business WireLongboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
29/11/202307:30Business WireLongboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy VolunteersNASDAQ:LBPHLongboard Pharmaceuticals Inc
21/11/202315:00Business WireLongboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy CommunityNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/11/202315:01Business WireLongboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/11/202315:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/11/202315:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/11/202307:30Business WireLongboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in NovemberNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/10/202315:05Business WireLongboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
19/09/202307:30Business WireLongboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
31/08/202315:00Business WireLongboard Pharmaceuticals to Participate in Three Upcoming Investor ConferencesNASDAQ:LBPHLongboard Pharmaceuticals Inc
30/08/202315:01Business WireLongboard Pharmaceuticals to Present Data at Upcoming Medical MeetingsNASDAQ:LBPHLongboard Pharmaceuticals Inc
23/08/202307:30Business WireLongboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic EncephalopathiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
13/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/08/202315:10Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/08/202315:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/08/202307:30Business WireLongboard Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:LBPHLongboard Pharmaceuticals Inc
26/06/202315:00Business WireLongboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023NASDAQ:LBPHLongboard Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:LBPH

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
NASDAQ
TSLA
Tesla
NYSE
BAC
Bank of America
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
FX
USDMXN
US Dollar vs MXN
USOTC
ADDYY
Adidas (QX)
NYSE
JPM
JP Morgan Chase
AMEX
XLV
Health Care Select Sector
NYSE
DIS
Walt Disney
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados